Cargando…
BayesPeak: Bayesian analysis of ChIP-seq data
BACKGROUND: High-throughput sequencing technology has become popular and widely used to study protein and DNA interactions. Chromatin immunoprecipitation, followed by sequencing of the resulting samples, produces large amounts of data that can be used to map genomic features such as transcription fa...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2760534/ https://www.ncbi.nlm.nih.gov/pubmed/19772557 http://dx.doi.org/10.1186/1471-2105-10-299 |
_version_ | 1782172752457760768 |
---|---|
author | Spyrou, Christiana Stark, Rory Lynch, Andy G Tavaré, Simon |
author_facet | Spyrou, Christiana Stark, Rory Lynch, Andy G Tavaré, Simon |
author_sort | Spyrou, Christiana |
collection | PubMed |
description | BACKGROUND: High-throughput sequencing technology has become popular and widely used to study protein and DNA interactions. Chromatin immunoprecipitation, followed by sequencing of the resulting samples, produces large amounts of data that can be used to map genomic features such as transcription factor binding sites and histone modifications. METHODS: Our proposed statistical algorithm, BayesPeak, uses a fully Bayesian hidden Markov model to detect enriched locations in the genome. The structure accommodates the natural features of the Solexa/Illumina sequencing data and allows for overdispersion in the abundance of reads in different regions. Moreover, a control sample can be incorporated in the analysis to account for experimental and sequence biases. Markov chain Monte Carlo algorithms are applied to estimate the posterior distributions of the model parameters, and posterior probabilities are used to detect the sites of interest. CONCLUSION: We have presented a flexible approach for identifying peaks from ChIP-seq reads, suitable for use on both transcription factor binding and histone modification data. Our method estimates probabilities of enrichment that can be used in downstream analysis. The method is assessed using experimentally verified data and is shown to provide high-confidence calls with low false positive rates. |
format | Text |
id | pubmed-2760534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27605342009-10-13 BayesPeak: Bayesian analysis of ChIP-seq data Spyrou, Christiana Stark, Rory Lynch, Andy G Tavaré, Simon BMC Bioinformatics Research Article BACKGROUND: High-throughput sequencing technology has become popular and widely used to study protein and DNA interactions. Chromatin immunoprecipitation, followed by sequencing of the resulting samples, produces large amounts of data that can be used to map genomic features such as transcription factor binding sites and histone modifications. METHODS: Our proposed statistical algorithm, BayesPeak, uses a fully Bayesian hidden Markov model to detect enriched locations in the genome. The structure accommodates the natural features of the Solexa/Illumina sequencing data and allows for overdispersion in the abundance of reads in different regions. Moreover, a control sample can be incorporated in the analysis to account for experimental and sequence biases. Markov chain Monte Carlo algorithms are applied to estimate the posterior distributions of the model parameters, and posterior probabilities are used to detect the sites of interest. CONCLUSION: We have presented a flexible approach for identifying peaks from ChIP-seq reads, suitable for use on both transcription factor binding and histone modification data. Our method estimates probabilities of enrichment that can be used in downstream analysis. The method is assessed using experimentally verified data and is shown to provide high-confidence calls with low false positive rates. BioMed Central 2009-09-21 /pmc/articles/PMC2760534/ /pubmed/19772557 http://dx.doi.org/10.1186/1471-2105-10-299 Text en Copyright © 2009 Spyrou et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Spyrou, Christiana Stark, Rory Lynch, Andy G Tavaré, Simon BayesPeak: Bayesian analysis of ChIP-seq data |
title | BayesPeak: Bayesian analysis of ChIP-seq data |
title_full | BayesPeak: Bayesian analysis of ChIP-seq data |
title_fullStr | BayesPeak: Bayesian analysis of ChIP-seq data |
title_full_unstemmed | BayesPeak: Bayesian analysis of ChIP-seq data |
title_short | BayesPeak: Bayesian analysis of ChIP-seq data |
title_sort | bayespeak: bayesian analysis of chip-seq data |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2760534/ https://www.ncbi.nlm.nih.gov/pubmed/19772557 http://dx.doi.org/10.1186/1471-2105-10-299 |
work_keys_str_mv | AT spyrouchristiana bayespeakbayesiananalysisofchipseqdata AT starkrory bayespeakbayesiananalysisofchipseqdata AT lynchandyg bayespeakbayesiananalysisofchipseqdata AT tavaresimon bayespeakbayesiananalysisofchipseqdata |